Inflammatory Biomarker Investigation

Chronic substance use is a powerful driver of systemic inflammation, and inflammation in turn worsens nearly every aspect of recovery — fatigue, body aches, sleep fragmentation, mood instability, cravings, and post-acute withdrawal symptoms. At RECO Island in Boynton Beach we treat inflammation as a measurable, modifiable problem rather than a vague background complaint. The investigation includes hsCRP, ESR, fibrinogen, ferritin (as an acute-phase reactant), and when clinically indicated, IL-6 and TNF-alpha. The numbers guide nutrition, IV therapy, sleep interventions, and supplement choices for the rest of the residential stay.

Chronic alcohol exposure inflames the liver, gut, and brain through several mechanisms simultaneously. Ethanol disrupts the intestinal barrier (leaky gut), allowing bacterial endotoxin (LPS) into circulation, which triggers Kupffer cells in the liver to release TNF-alpha and IL-6. The resulting hepatic inflammation shows up as elevated GGT, AST, and CRP, and the systemic cytokine load drives the depressive, foggy, achey feeling that lingers weeks into sobriety. Treating the inflammation directly — with hydration, omega-3s, glutathione, and gut-repair nutrition — speeds resolution of these symptoms.

Very. Opioids slow GI motility, alter the microbiome, and promote bacterial translocation across an inflamed gut wall. Lipopolysaccharide (LPS) circulating from the gut is one of the most potent inflammatory triggers in the body and is now linked to opioid-induced fatigue, anhedonia, and prolonged post-acute withdrawal. Our medical team at RECO Island uses inflammatory markers alongside symptom tracking to decide which patients benefit from gut-rebuilding interventions — probiotics, L-glutamine, digestive enzymes, anti-inflammatory nutrition, and in select cases, IV glutathione — layered on top of standard medical detox.

Treatment is layered and matched to the marker. Elevated hsCRP with a clean infectious workup typically responds to omega-3 fatty acids (2 to 4 grams EPA/DHA daily), a lower-glycemic anti-inflammatory meal plan from our culinary team, restoration of vitamin D and magnesium when deficient, sleep stabilization, and gentle aerobic movement once medically cleared. NAC and glutathione, often delivered via IV in early detox, help rebuild antioxidant capacity. Persistent elevations after the active detox phase trigger a deeper workup — liver, thyroid, autoimmune — rather than masking the symptom.

The evidence increasingly says yes. Post-acute withdrawal syndrome (PAWS) — the weeks-to-months stretch of low mood, irritability, sleep disruption, and cognitive dullness after acute detox resolves — overlaps significantly with sickness behavior driven by elevated inflammatory cytokines. Patients with persistently high CRP or IL-6 at the end of detox tend to have a longer, harder PAWS course. That is why the inflammation workup at RECO Island is not a one-time admission lab; we re-check key markers before residential discharge and use the trajectory to plan aftercare nutrition, supplementation, and outpatient medical follow-up.

The standard markers — hsCRP, ESR, fibrinogen, ferritin, complete metabolic panel — are routinely reimbursed by all major commercial insurance plans (Aetna, BlueCross BlueShield, Cigna, United, Optum, Magellan, Humana) and managed Medicaid when ordered as part of substance-use-disorder treatment. Specialty cytokine panels (IL-6, TNF-alpha) and advanced GI permeability markers are sometimes billed as send-out tests with variable coverage; our admissions team flags any non-covered lab in advance so there are no surprises. The investigation is part of the bundled detox per-diem in most contracts and is not billed separately to the patient.